Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd.’s Net Profit Rose 24.6% in First Half of 2023

Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd. (江苏诺泰澳赛诺生物制药股份有限公司) (688076.SH) reported a net profit of 39.9 million yuan in the first half of 2023, up 24.6% year-on-year.

Meanwhile, the company posted 400.8 million yuan in revenue, up 49.4% year-on-year.

At the end of the reporting period, it had 2.6 billion yuan in total assets and 694.1 million yuan in total liabilities, with a liability-to-asset ratio of 26.5%.